Both in Pharmaceuticals
Innovator U.S. Equity Ultra Buffer ETF - November vs Calamos S&P 500 Structured Alt Protection ETF - March
Over the past year UNOV returned +10.4% and CPSR returned +5.6%; their daily moves had a correlation of 0.81.
UNOV +10.4% CPSR +5.6%Growth of $1, one year, split-adjusted
| Metric | UNOV | CPSR |
|---|---|---|
| Price | $41.36 | $26.19 |
| Market cap | $106.5M | $34.0M |
| Today | −0.24% | +0.03% |
| 1 month | +0.6% | +0.3% |
| 6 months | +12.4% | +3.9% |
| Year to date | +8.7% | +3.9% |
| 1 year | +10.7% | +5.8% |
| Revenue growth (YoY) | +3.0% | −87.7% |
| Gross margin | 69.0% | 55.0% |
| Net margin | 8.0% | −693.9% |
| P/E (TTM) | 27.4× | — |
| Price / sales | 3.0× | 2.8× |
| Net cash | $2.8M | -$52.7M |
| Dividend yield | — | — |
| Volatility (60d) | 5.1% | 1.6% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).